TEL AVIV, Israel and NEW YORK, Feb. 28, 2017 -- Perion Network Ltd. (NASDAQ:PERI), today announced that it will release its financial results for the fourth quarter and year ended December 31, 2016, on March 7, 2017 prior to the opening of the market. Management will host a conference call to discuss the results at 10 a.m. ET that day.
Details are as follows:
- Conference ID: 1383778
- Dial-in number from within the United States: 1-888-599-8667
- Dial-in number from Israel: 1-809-258-350
- Dial-in number (other international): 1-913-312-0836
- Playback available until March 14, 2017 by calling 1-844-512-2921 (United States) or 1-412-317-6671 (international). Please use PIN code 1383778 for the replay.
- Link to the live webcast accessible at http://www.perion.com/ir-events
About Perion Network Ltd.
Perion is a global technology company that delivers high-quality advertising solutions to brands and publishers. Perion is committed to providing outstanding execution, from high-impact ad formats to branded search and a unified social and mobile programmatic platform. More information about Perion may be found at www.perion.com, and follow Perion on Twitter @perionnetwork.
Source: Perion Network Ltd.
Contact Information: Perion Network Ltd. Investor Relations Neta Fishman +972 (73) 398-1000 [email protected]


China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



